COMMUNITY HEALTH SYSTEMS INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent ($1.7b) ($2.5b) ($788.0m) ($675.0m) $511.0m $230.0m $46.0m ($133.0m) ($516.0m) $509.0m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest ($1.6b) ($2.4b) ($704.0m) ($590.0m) $607.0m $368.0m $179.0m $16.0m ($362.0m) $676.0m
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent ($1.7b) ($2.4b) ($788.0m) ($675.0m)
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($1.6b) ($2.4b) ($704.0m) ($590.0m)
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($15.0m) ($12.0m)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent ($15.0m) ($12.0m)
Net Income (Loss) Attributable to Noncontrolling Interest $95.0m $63.0m $84.0m $85.0m $96.0m $138.0m $133.0m $149.0m $154.0m $167.0m
Depreciation, Depletion and Amortization $1.1b $861.0m $700.0m $608.0m $558.0m $540.0m $534.0m $505.0m $486.0m $426.0m
Deferred Income Tax Expense (Benefit) ($116.0m) ($454.0m) ($3.0m) $203.0m ($187.0m) $171.0m $165.0m $35.0m ($116.0m) ($243.0m)
Share-based Payment Arrangement, Noncash Expense $46.0m $24.0m $13.0m $10.0m $13.0m $25.0m $20.0m $22.0m $17.0m $11.0m
Payment, Tax Withholding, Share-based Payment Arrangement $6.0m $5.0m $1.0m $1.0m $1.0m $5.0m $8.0m $4.0m $1.0m $2.0m
Gain (Loss) on Sale of Assets and Asset Impairment Charges ($48.0m) $24.0m
Goodwill, Impairment Loss $1.4b $1.4b $0 $0 $0 $0 $0 $0 $0 $0
Equity Method Investment, Realized Gain (Loss) on Disposal $94.0m $39.0m
Gain (Loss) on Extinguishment of Debt ($30.0m) ($40.0m) $31.0m ($54.0m) $317.0m ($79.0m) $253.0m $72.0m $25.0m $97.0m
Income (Loss) from Equity Method Investments $43.0m $16.0m $22.0m $15.0m $10.0m $22.0m $14.0m $8.0m $10.0m $9.0m
Income Tax Expense (Benefit) ($104.0m) ($449.0m) ($11.0m) $160.0m ($185.0m) $131.0m $170.0m $191.0m $79.0m $48.0m
Operating Lease, Expense $308.0m $317.0m $319.0m $299.0m $277.0m
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable $96.0m ($732.0m) ($31.0m) ($93.0m) ($309.0m) $136.0m ($22.0m) $193.0m $66.0m ($99.0m)
Equity Securities, FV-NI, Realized Gain (Loss) ($7.0m) $15.0m $9.0m $20.0m ($28.0m) $11.0m $8.0m $10.0m
Gain (Loss) Related to Litigation Settlement $31.0m ($11.0m) ($93.0m)
Goodwill $6.5b $4.7b $4.6b $4.3b $4.2b $4.2b $4.2b $4.0b $3.8b $3.3b
Investment Income, Interest $14.0m $11.0m $7.0m $3.0m $3.0m $3.0m $2.0m $2.0m $3.0m $2.0m
Payments of Financing Costs $26.0m $66.0m $96.0m $46.0m $156.0m $313.0m $74.0m $3.0m $9.0m $16.0m
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax ($7.0m) ($6.0m)
Net Cash Provided by (Used in) Operating Activities $1.1b $773.0m $274.0m $385.0m $2.2b ($131.0m) $300.0m $210.0m $480.0m $543.0m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $744.0m $564.0m $527.0m $438.0m $440.0m $469.0m $415.0m $467.0m $360.0m $335.0m
Payments to Acquire Businesses, Net of Cash Acquired $123.0m $6.0m $26.0m $13.0m $1.0m $3.0m $9.0m $38.0m $25.0m $1.0m
Payments to Acquire Investments $78.0m $80.0m $178.0m $171.0m $114.0m $137.0m $81.0m $139.0m
Payments for (Proceeds from) Other Investing Activities $242.0m $143.0m $141.0m $170.0m $50.0m $113.0m $60.0m $65.0m $59.0m $63.0m
Net Cash Provided by (Used in) Investing Activities $630.0m $1.1b ($245.0m) ($2.0m) $177.0m ($524.0m) ($259.0m) ($26.0m) ($275.0m) $847.0m
Cash flows from financing activities:
Repayments of Long-term Debt $6.7b $5.4b $2.0b $3.6b $5.5b $4.4b $2.4b $4.3b $5.1b $6.5b
Proceeds from Noncontrolling Interests $10.0m $15.0m $13.0m $5.0m $1.0m $2.0m
Net Cash Provided by (Used in) Financing Activities ($1.7b) ($1.5b) ($396.0m) ($363.0m) ($895.0m) ($514.0m) ($430.0m) ($264.0m) ($206.0m) ($1.2b)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1.5b ($1.2b) ($389.0m) ($80.0m) ($1.0m) $223.0m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $216.0m $1.7b $507.0m $118.0m $38.0m $37.0m $260.0m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $930.0m $852.0m $936.0m $1.0b $1.0b $778.0m $835.0m $801.0m $741.0m $804.0m
Income Taxes Paid, Net ($16.0m) $4.0m $19.0m $3.0m ($2.0m) ($4.0m) ($6.0m) ($91.0m) ($171.0m) $249.0m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.